MarketWatch
January 17, 2025 at 07:55 PM
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.
FDA authorizes the marketing of 20 Zyn products because they pose fewer health risks than cigarettes and most smokeless products. https://trib.al/pnLWkpW
👍
❤️
😂
🙏
14